Saturday, January 09, 2021 11:10:15 AM
On January 1, 2021, I asked this board's members to give their prediction of the PPS of $AMRN on December 31, 2021, or if bought out before, a prediction of the buyout price.
By January 8, 2021, 128 people replied with their predictions - thank you, all. Here are the results:
Average (n = 128): $25.31
Average after discarding top 10% & bottom 10% (n = 102): $23.21
Median (n = 128): $22.75
4.87 biofalcon
4.89 Tal10
5.25 hoggydog
5.30 wodehouse
6.00 shakyman
6.50 amarinbullfromchicago
6.66 Abe1234
7.25 Amarin_Buyout
7.50 MNBioMike
7.75 BioBS2012
9.00 newtotheparty
9.75 ralphey
9.75 The Canes
10.50 mrmainstreet
10.50 lizzy241
10.90 L0tsaluck2000
11.00 DKNY1
11.80 bfost
12.00 berryfitRD
12.00 ziploc_1
12.20 niall75
12.50 lbwagain
12.75 Crikker
13.00 shadolane
13.00 Babr
13.00 hamkypamky
13.13 Scallops
13.50 ambiente
13.85 Value in the end
14.00 Lizaa
14.00 TerraPharma1
14.50 too simple
14.99 TastyTheElf
15.00 Jimcal22
15.00 Retired2019
15.55 Dingo8833
16.00 Megc
16.00 dukesking
16.00 Invest83838
16.00 heysfguy
16.80 Danouse
16.90 studythosestocks
17.00 Rafunrafun (+CVR)
17.50 Notademoc
17.92 fsulevine
18.00 Gusman
18.00 stock-guru
18.00 lorbas95
18.20 Hondo1021
18.50 DD222
18.50 Hey Jakey
18.50 kjones3701
18.88 Triple88
19.00 DirteeHarree
19.00 rosemountbomber
19.37 soupertrooper
19.75 stoneroad
20.00 tm100
21.56 Realcool11
21.00 Larrybirdlegend (+CVR)
22.00 juslin
22.00 alm2
22.00 momoney24
22.50 oneragman
23.00 Bolio98
23.50 gamechanger101
23.45 Toddrobertking
23.50 mag6898
24.00 couldbebetter
24.00 Lemmiwinks
24.00 Examiner77
24.30 louieblouie
24.50 Nibblerx16
24.75 best golfer
24.95 hankbb02
25.00 BobWayne
25.00 Chemist2
25.00 Irish guy 009
25.00 USAFC130
25.00 Gbert
25.67 funnygi2
25.70 rtc110
26.00 retinadoc
26.00 alwayswatching1
26.00 Downtownguy
26.00 CaptBeer
26.50 rydad21
26.69 luvbio
27.50 kevin1231
27.55 Martinko
28.50 FesteringPus
29.99 massulo52
30.00 money_man
30.00 BrunoGOudega
30.00 FlyFishingStocks
31.50 hump4
32.00 Glycol
32.50 DAR53
33.77 hayward
35.00 Emptytomb
35.00 Retiredceo
35.00 BioBull
35.00 MA52TA
35.00 Bluensleepy
35.00 xblkbk
35.00 Number sleven
36.00 sstyles
36.66 invest2992
36.81 grbnitz4002 (1 $PFE)
40.00 north40000
43.00 Vegas8ball
43.75 bidmark
44.00 Monk44
44.00 Pterion
44.00 NI- bound
45.00 noelan_s09
46.25 picasel
47.00 ORBAPU
48.00 ramfan60
50.00 golf stud
50.00 iryokabu
52.00 creynolds
52.00 finh
55.00 jasbg
60.00 scxj
66.00 Freifaller
100.00 situ
110.00 Biobillionair
Recent AMRN News
- Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual Europe • GlobeNewswire Inc. • 09/09/2024 11:30:00 AM
- Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress • GlobeNewswire Inc. • 08/22/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 09:30:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 08:54:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 08:54:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 11:05:34 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2024 11:05:26 AM
- Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 07/31/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 09:30:08 PM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal • GlobeNewswire Inc. • 07/17/2024 08:15:00 PM
- Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024 • GlobeNewswire Inc. • 07/17/2024 12:00:00 PM
- Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR) • GlobeNewswire Inc. • 07/08/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM